Abstract
Andrzej Fedak, Krystian Mirowski, Jan Jamroś, Agnieszka Czapska, Patrycja Mensah‐Glanowska, Michał Kukla
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Ultrasonography in patients with Budd‐Chiari syndrome: diagnostic signs and prognostic implications
10.1016/j.jhep.2008.04.025 · 2008
Budd‐Chiari syndrome: spectrum of imaging findings
10.2214/ajr.05.0168 · 2007
Budd‐Chiari syndrome: a review of imaging findings
10.1016/j.ejrad.2006.11.004 · 2007
Budd‐Chiari syndrome: diagnosis with three‐dimensional contrast‐enhanced magnetic resonance angiography
10.3748/wjg.v9.i10.2317 · 2003
Primary Budd‐Chiari syndrome
10.1016/j.jhep.2008.10.007 · 2009
10.1016/j.jhep.2025.08.001
10.1016/j.jhep.2025.08.001
10.1148/rg.240240
10.1148/rg.240240
10.1007/s00261-024-04558-4
10.1007/s00261-024-04558-4
10.7759/cureus.96539
10.7759/cureus.96539
EASL clinical practice guidelines: vascular diseases of the liver
10.1016/j.jhep.2015.07.040 · 2016
The Budd‐Chiari syndrome
10.1056/nejmra020282 · 2004
Budd‐Chiari syndrome
10.1055/s-0028-1085094 · 2008
Vascular disorders of the liver
10.1002/hep.22772 · 2009
Budd‐Chiari syndrome management: controversies and open issues
10.3390/diagnostics12112670 · 2022
Update on the classification, assessment of prognosis and therapy of Budd‐Chiari syndrome
10.1038/ncpgasthep0143 · 2005
10.5306/wjco.v14.i3.99
10.5306/wjco.v14.i3.99
Ravulizumab (ALXN1210) vs eculizumab in adult patients with paroxysmal nocturnal hemoglobinuria naive to complement inhibitors: the 301 study
10.1182/blood-2018-09-876136 · 2019
The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria
10.1056/nejmoa061648 · 2006
Paroxysmal nocturnal hemoglobinuria
10.1182/blood-2014-02-522128 · 2014
10.3390/ijms252212104
10.3390/ijms252212104
10.1182/blood.2024023988
10.1182/blood.2024023988
Budd‐Chiari syndrome: the “inferior vena cava reverse‐flow” sign and “jet‐blood” sign on CT and MRI
10.1016/j.ejrad.2020.109288 · 2020
10.1016/s0009-9260(97)80135-3
10.1016/s0009-9260(97)80135-3
10.3389/fsurg.2022.951514
10.3389/fsurg.2022.951514
10.1007/978-1-4419-8327-5
10.1007/978-1-4419-8327-5 · 2011
10.14309/ajg.0000000000003886
10.14309/ajg.0000000000003886
10.1055/a-1550-3141
10.1055/a-1550-3141
10.1159/000549007
10.1159/000549007
10.1007/s00330-026-12433-7
10.1007/s00330-026-12433-7
10.1002/jcu.70136
10.1002/jcu.70136
Guidelines and good clinical practice recommendations for contrast‐enhanced ultrasound (CEUS) in the liver ‐ update 2020 ‐ WFUMB in cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS
10.1055/a-1177-0530 · 2020
Contrast‐enhanced ultrasound imaging of the liver: a review of the clinical evidence for SonoVue and Sonazoid
10.1007/s00261-020-02573-9 · 2020
10.1016/j.ejrad.2012.01.023
10.1016/j.ejrad.2012.01.023
An EFSUMB introduction into dynamic contrast‐enhanced ultrasound (DCE‐US) for quantification of tumour perfusion
10.1055/s-0032-1313026 · 2012
10.1097/ruq.0000000000000515
10.1097/ruq.0000000000000515
10.3748/wjg.v23.i43.7765
10.3748/wjg.v23.i43.7765
10.1259/bjr.20190847
10.1259/bjr.20190847
10.1016/j.tvir.2025.101087
10.1016/j.tvir.2025.101087
10.1002/jcu.23210
10.1002/jcu.23210
10.1371/journal.pone.0197550
10.1371/journal.pone.0197550
10.7863/ultra.15.09026
10.7863/ultra.15.09026 · doi-reference
Italian Society for Ultrasound in medicine and biology (SIUMB) study group on ultrasound contrast agents. The safety of SonoVue in abdominal applications: retrospective analysis of 23188 investigations
10.1016/j.ultrasmedbio.2006.05.031 · doi-reference
10.3892/etm.2013.1105
10.3892/etm.2013.1105 · doi-reference
10.2214/ajr.21.26547
10.2214/ajr.21.26547 · doi-reference
10.1016/j.jvir.2016.11.091
10.1016/j.jvir.2016.11.091 · doi-reference